Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ichthyosis prematurity syndrome is a rare, syndromic congenital ichthyosis characterized by premature birth (at gestational weeks 30-32, in general) in addition to thick, caseous and desquamating epidermis, neonatal respiratory asphyxia, and persistent eosinophilia. After the perinatal period, a spontaneous improvement in the health of affected patients is observed and skin features (vernix caseosa-like scale) evolve into a mild presentation of flat follicular hyperkeratosis with atopy.
Features include always present findings: Polyhydramnios, Epidermal acanthosis, Neonatal asphyxia, and Caseous vernix-like desquamation and others; and sometimes findings: Asthma, Alopecia of scalp, Allergic rhinitis, and Food allergy. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 6 | Alopecia of scalp, Dermatographic urticaria, Hyperpigmentation of the skin |
SLC27A4 function has not been fully characterized.
Ichthyosis prematurity syndrome is associated with mutations in the SLC27A4 gene on chromosome 9.
Genetic testing for SLC27A4 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for ichthyosis prematurity syndrome has been reported in the published literature.
Phenotype severity distribution: 9 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ichthyosis prematurity syndrome.
37 publications have been identified in PubMed for ichthyosis prematurity syndrome. Research spans Case Report / Case Series (30%), Review / Meta-Analysis (22%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 11 | 30% |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 2:44 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Lungs and breathing |
1 |
Asthma |
Pregnancy and birth | 1 | Neonatal asphyxia |
Age of onset: at birth, before birth.
Research summaries
8 |
22% |
Laboratory research | 5 | 14% |
Disease patterns and progression | 5 | 14% |
Testing and diagnosis research | 3 | 8% |
Clinical study results | 2 | 5% |
New treatment approaches | 2 | 5% |
Other research | 1 | 3% |
Smith MA (2026). [PMID: 41248753](https://pubmed.ncbi.nlm.nih.gov/41248753/). *Transplantation and cellular therapy*. [Diagnostic / Biomarker]
Srikanthan MA (2026). [PMID: 41983728](https://pubmed.ncbi.nlm.nih.gov/41983728/). *Curr Opin Pediatr*. [Epidemiology / Natural History]
Gupta AO (2026). [PMID: 41931046](https://pubmed.ncbi.nlm.nih.gov/41931046/). *The New England journal of medicine*. [Gene Therapy / Novel Therapeutics]
Dekker L (2026). [PMID: 41896325](https://pubmed.ncbi.nlm.nih.gov/41896325/). *Bone marrow transplantation*. [Epidemiology / Natural History]
Gironi LC (2026). [PMID: 41805040](https://pubmed.ncbi.nlm.nih.gov/41805040/). *Italian journal of dermatology and venereology*. [Basic Science / Preclinical]
Sano H (2026). [PMID: 41800496](https://pubmed.ncbi.nlm.nih.gov/41800496/). *Pediatric hematology and oncology*. [Clinical Trial Publication]
Gupta N (2026). [PMID: 41883777](https://pubmed.ncbi.nlm.nih.gov/41883777/). *World journal of critical care medicine*. [Review / Meta-Analysis]
Yokokawa T (2026). [PMID: 42221089](https://pubmed.ncbi.nlm.nih.gov/42221089/). *Front Med (Lausanne)*. [Diagnostic / Biomarker]
Luboń W (2026). [PMID: 42072832](https://pubmed.ncbi.nlm.nih.gov/42072832/). *Diagnostics (Basel)*. [Diagnostic / Biomarker]
Li GX (2025). [PMID: 40000070](https://pubmed.ncbi.nlm.nih.gov/40000070/). *Pediatric dermatology*. [Review / Meta-Analysis]